Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC400568 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TIGD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ADSSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC100505478 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOX12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPRC5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35E3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCTP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP2R1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNMA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRDT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYPD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARD6G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on